Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Christoffer Martinussen, Kirstine Nyvold Bojsen-Moller, Maria Saur Svane, Thomas Fremming Dejgaard & Sten Madsbad. (2017) Emerging drugs for the treatment of obesity. Expert Opinion on Emerging Drugs 22:1, pages 87-99.
Read now
Read now
Felipe Gil, Arthur Guerra de Andrade & João Maurício Castaldelli-Maia. (2016) Discussing prevalence, impacts, and treatment of substance use disorders in athletes. International Review of Psychiatry 28:6, pages 572-578.
Read now
Read now
Cristoforo Silvestri & Vincenzo Di Marzo. (2012) Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders. Expert Opinion on Investigational Drugs 21:9, pages 1309-1322.
Read now
Read now
Articles from other publishers (111)
Seyed Ehsan Mousavi, Farhad Tondro Anamag & Sarvin Sanaie. (2023) Association between cannabis use and risk of diabetes mellitus type 2: A systematic review and meta‐analysis. Phytotherapy Research 37:11, pages 5092-5108.
Crossref
Crossref
Lisa R. Miller-Matero, Kaitlin Ross, Camila Arellano, Logan Zelenak, Eve DePascale, Lyubov Gavrilova, Jordan M. Braciszewski, Leah M. Hecht, Erin N. Haley, Carly Brescacin & Arthur M. Carlin. (2023) Cannabis use following bariatric surgery is associated with anxiety and maladaptive eating. Surgery for Obesity and Related Diseases.
Crossref
Crossref
Ioana Creanga-Murariu, Leontina Elena Filipiuc, Magda Cuciureanu, Bogdan-Ionel Tamba & Teodora Alexa-Stratulat. (2023) Should oncologists trust cannabinoids?. Frontiers in Pharmacology 14.
Crossref
Crossref
José Francisco López-Gil, Lee Smith, Anelise Reis Gaya, Desirée Victoria-Montesinos, Héctor Gutiérrez-Espinoza, Eva Herrera-Gutiérrez & Antonio García-Hermoso. (2023) The moderating role of recreational substance use in the association of Mediterranean diet with academic performance among adolescents. Scientific Reports 13:1.
Crossref
Crossref
Kamleshun Ramphul, Petras Lohana, Renuka Verma, Nomesh Kumar, Yogeshwaree Ramphul, FNU Arti, Shaheen Sombans, Stephanie Gonzalez Mejias & Komal Kumari. (2023) Acute Ischemic Stroke Among Cannabis Users in the United States and Possible Risk Factors for Mortality. The Neurologist 28:4, pages 226-230.
Crossref
Crossref
Sonia Samuel, Mark Michael & Micheal Tadros. (2023) Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns. World Journal of Clinical Cases 11:18, pages 4210-4230.
Crossref
Crossref
Carlos A. Lafourcade, Fraser T. Sparks, Angelique Bordey, Ursula Wyneken & Michael H. Mohammadi. (2023)
Cannabinoid regulation of neurons in the dentate gyrus during epileptogenesis: Role of
CB1R
‐associated proteins and downstream pathways
. Epilepsia 64:6, pages 1432-1443.
Crossref
Crossref
Lisa R. Miller-Matero, Kaitlin Ross, Eve DePascale, Camila Arellano, Logan Zelenak, Jordan M. Braciszewski, Leah M. Hecht, Erin N. Haley, Amy M. Loree & Arthur M. Carlin. (2023) Post-surgical cannabis use is associated with weight loss among individuals up to 4 years after bariatric surgery. Surgical Endoscopy.
Crossref
Crossref
Camelia Munteanu & Betty Schwartz. (2023) The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease. Antioxidants 12:4, pages 903.
Crossref
Crossref
Estella Y. Huang, Ryan C. Broderick, Jonathan Z. Li, Joaquin L. Serra, Pranav Ahuja, Samantha Wu, Michael Genz, Eduardo Grunvald, David C. Kunkel, Bryan J. Sandler, Santiago Horgan & Garth R. Jacobsen. (2022) Weight loss outcomes are not compromised in bariatric patients using cannabis. Surgical Endoscopy 37:3, pages 2194-2201.
Crossref
Crossref
Arcangelo Barbonetti, Giulia Rastrelli, Clotilde Sparano, Chiara Castellini, Linda Vignozzi, Mario Maggi & Giovanni Corona. (2023) Is marijuana a foe of male sexuality?: Data from a large cohort of men with sexual dysfunction. Andrology.
Crossref
Crossref
Reem Ghazali & Vinood B. Patel. 2023. Neurobiology and Physiology of the Endocannabinoid System. Neurobiology and Physiology of the Endocannabinoid System
507
518
.
Melissa McHann, Robert Barnes, Isabel Castro-Piedras & Josée Guindon. 2023. Neurobiology and Physiology of the Endocannabinoid System. Neurobiology and Physiology of the Endocannabinoid System
529
541
.
Justin R. Yates. 2023. Determinants of Addiction. Determinants of Addiction
3
41
.
Joao P. Silva & Felix Carvalho. (2022) The therapeutic use of cannabis and cannabinoids. Revista Española de Drogodependencias 47:4, pages 123-141.
Crossref
Crossref
Joao P. Silva & Felix Carvalho. (2022) El uso terapéutico del cannabis y los cannabinoides. Revista Española de Drogodependencias 47:4, pages 103-122.
Crossref
Crossref
Raymond J. March, Veeshan Rayamajhee & Glenn L. Furton. (2022) Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity. Health Economics 31:12, pages 2609-2629.
Crossref
Crossref
Valentina Razmovski-Naumovski, Tim Luckett, Ingrid Amgarth-Duff & Meera R Agar. (2022) Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review. Palliative Medicine 36:6, pages 912-927.
Crossref
Crossref
Shana M. Augustin & David M. Lovinger. (2022) Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of Disease 167, pages 105670.
Crossref
Crossref
Himank GuptaSnehil GuptaAbhijit R. Rozatkar. (2021) Magnitude of Substance Use and Its Associated Factors Among the Medical Students in India and Implications for Medical Education: A Narrative Review. Indian Journal of Psychological Medicine 44:3, pages 218-226.
Crossref
Crossref
Jenny G Turcott, Zyanya Lucia Zatarain-Barrón, Daniela Cárdenas Fernández, Diana Tamara Castañares Bolaños & Oscar Arrieta. (2022)
Appetite stimulants for
patients with cancer: current evidence for clinical practice
. Nutrition Reviews 80:4, pages 857-873.
Crossref
Crossref
Andrea Glenn, Meaghan Kavanagh, Laura Bockus‐Thorne, Lauren McNeill, Vesanto Melina, David Jenkins & Shannan Grant. 2022. Clinical Pain Management. Clinical Pain Management
147
159
.
Lucile Simon, Christine Baldwin, Anastasia Z. Kalea & Adrian Slee. (2021) Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle 13:1, pages 23-41.
Crossref
Crossref
Natalia Szejko & Kirsten Müller-Vahl. 2022. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B
269
294
.
Luca Busetto, Silvia Bettini, Janine Makaronidis, Carl A. Roberts, Jason C.G. Halford & Rachel L. Batterham. (2021) Mechanisms of weight regain.. European Journal of Internal Medicine 93, pages 3-7.
Crossref
Crossref
Jamie van Son, Katy A. van Galen, Anne Marijn Bruijn, Karin E. Koopman, Ruth I. Versteeg, Susanne E. la Fleur, Mireille J. Serlie & Jan Booij. (2021) Striatal Dopamine Transporter Availability Is Not Associated with Food Craving in Lean and Obese Humans; a Molecular Imaging Study. Brain Sciences 11:11, pages 1428.
Crossref
Crossref
Marialuisa de Ceglia, Juan Decara, Silvana Gaetani & Fernando Rodríguez de Fonseca. (2021) Obesity as a Condition Determined by Food Addiction: Should Brain Endocannabinoid System Alterations Be the Cause and Its Modulation the Solution?. Pharmaceuticals 14:10, pages 1002.
Crossref
Crossref
Zhipeng Cao, Andrew M. Scott, Nick J. Hoogenraad & Laura D. Osellame. (2021) Mediators and clinical treatment for cancer cachexia: a systematic review. JCSM Rapid Communications 4:2, pages 166-186.
Crossref
Crossref
Luis Rodrigo Arnabal. (2021) Optimal design of sin taxes in the presence of nontaxable sin goods. Health Economics 30:7, pages 1580-1599.
Crossref
Crossref
Rhiannon M Armitage, Vasiliki Iatridi & Martin R Yeomans. (2021) Understanding sweet-liking phenotypes and their implications for obesity: Narrative review and future directions. Physiology & Behavior 235, pages 113398.
Crossref
Crossref
Klaudia Berk, Wiktor Bzdega, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, Hubert Zywno & Adrian Chabowski. (2021) Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment. Journal of Clinical Medicine 10:3, pages 393.
Crossref
Crossref
Bapi Gorain, Hira Choudhury, Pallav Sengupta, Rohit Kumar Verma & Manisha Pandey. 2021. Obesity and its Impact on Health. Obesity and its Impact on Health
125
148
.
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Isabelle Claudet, Sophie Breinig, Michel Lavit, Lucas Ricco, Camille Brehin & Souleiman El Balkhi. (2020) Is there an interest for hair analysis in non-intentional pediatric cannabis intoxication?. Forensic Science International 313, pages 110377.
Crossref
Crossref
John A. Karas, Labell J. M. Wong, Olivia K. A. Paulin, Amna C. Mazeh, Maytham H. Hussein, Jian Li & Tony Velkov. (2020) The Antimicrobial Activity of Cannabinoids. Antibiotics 9:7, pages 406.
Crossref
Crossref
Arianna Giorgetti, Lukas Mogler, Sebastian Halter, Belal Haschimi, Andreas Alt, Daniel Rentsch, Bea Schmidt, Vanessa Thoma, Susanne Vogt & Volker Auwärter. (2019) Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE. Forensic Toxicology 38:2, pages 314-326.
Crossref
Crossref
Carl A Roberts, Timo Giesbrecht, Nicholas Fallon, Anna Thomas, David J Mela & Tim C Kirkham. (2020) A Systematic Review and Activation Likelihood Estimation Meta-Analysis of fMRI Studies on Sweet Taste in Humans. The Journal of Nutrition 150:6, pages 1619-1630.
Crossref
Crossref
Primali V. Navaratne, Jenny L. Wilkerson, Kavindri D. Ranasinghe, Evgeniya Semenova, Jasmine S. Felix, Ion Ghiviriga, Adrian Roitberg, Lance R. McMahon & Alexander J. Grenning. (2020) Axially Chiral Cannabinols: A New Platform for Cannabinoid‐Inspired Drug Discovery. ChemMedChem 15:9, pages 728-732.
Crossref
Crossref
Claudio D'Addario, Elizabeta Zaplatic, Elisa Giunti, Mariangela Pucci, Maria Vittoria Micioni Di Bonaventura, Maria Scherma, Enrico Dainese, Mauro Maccarrone, Ida A. Nilsson, Carlo Cifani & Paola Fadda. (2020)
Epigenetic regulation of the cannabinoid receptor
CB1
in an activity‐based rat model of anorexia nervosa
. International Journal of Eating Disorders 53:5, pages 702-716.
Crossref
Crossref
Mehdi Farokhnia, Gray R. McDiarmid, Matthew N. Newmeyer, Vikas Munjal, Osama A. Abulseoud, Marilyn A. Huestis & Lorenzo Leggio. (2020) Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Translational Psychiatry 10:1.
Crossref
Crossref
Megan E. Ames, Bonnie J. Leadbeater, Gabriel J. Merrin & Kara Thompson. (2018) Patterns of marijuana use and physical health indicators among Canadian youth. International Journal of Psychology 55:1, pages 1-12.
Crossref
Crossref
S. Kuderer, E. Helmert, H. Szöke, S. Joos, M. Kohl, J. Svaldi, F. Beissner, F. Andrasik & J. Vagedes. (2020) Increasing Warmth in Adolescents with Anorexia Nervosa: A Randomized Controlled Crossover Trial Examining the Efficacy of Mustard and Ginger Footbaths. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-14.
Crossref
Crossref
Florence St-GermainDt.P. M. SDt.P. M. S. (2020) Les habitudes alimentaires des usagers de cannabis : mieux les comprendre pour mieux intervenir. Nutrition Science en évolution 18:2, pages 16-21.
Crossref
Crossref
Fabienne Saint-Preux, Arpit Arora, Derek Moriyama, Esther Kim & Arum Kim. 2020. Cannabis in Medicine. Cannabis in Medicine
345
372
.
Mensah* Kwesi Boadu & Adu-Gyamfi Paa Kofi Tawiah. (2019) To legalize cannabis in Ghana or not to legalize? Reviewing the pharmacological evidence. Archives of Pharmacy and Pharmaceutical Sciences 3:1, pages 082-088.
Crossref
Crossref
Elise Wouters, Jolien Walraed, Samuel D. Banister & Christophe P. Stove. (2019) Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists. Biochemical Pharmacology 169, pages 113623.
Crossref
Crossref
Carl A Roberts, Gerry Jager, Paul Christiansen & Tim C Kirkham. (2019) Exploring the munchies: An online survey of users’ experiences of cannabis effects on appetite and the development of a Cannabinoid Eating Experience Questionnaire. Journal of Psychopharmacology 33:9, pages 1149-1159.
Crossref
Crossref
Vikram Rao B. Vasanth Rao, Mayuren Candasamy & Subrat Kumar Bhattamisra. (2019) Obesity an overview: Genetic conditions and recent developments in therapeutic interventions. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:3, pages 2112-2120.
Crossref
Crossref
Nathalie Weltens, Inge Depoortere, Jan Tack & Lukas Van Oudenhove. (2019) Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled study. The American Journal of Clinical Nutrition 109:4, pages 1051-1063.
Crossref
Crossref
Omar Al Massadi, Ruben Nogueiras, Carlos Dieguez & Jean-Antoine Girault. (2019) Ghrelin and food reward. Neuropharmacology 148, pages 131-138.
Crossref
Crossref
Eva Hoch, Miriam Schneider, Rupert von Keller, Udo Bonnet, Peter Falkai, Alkomiet Hasan, Winfried Häuser, Burkhard Hinz, Luise Jakob, Johannes Kabisch, Ludwig Kraus, Dominik Niemann, Frank Petzke, Oliver Pogarell, Ulrich Preuss, Lukas Radbruch, Nina Sarubin, Kathrin Schacherbauer, Michael Schäfer, Martin Storr & Chris Maria Friemel. 2019. Cannabis: Potenzial und Risiko. Cannabis: Potenzial und Risiko
265
426
.
Giulia Gattere, Alexander Stojanovic-Pérez, Rosa Monseny, Lourdes Martorell, Laura Ortega, Itziar Montalvo, Montse Solé, María José Algora, Ángel Cabezas, Rebecca M. Reynolds, Elisabet Vilella & Javier Labad. (2018) Gene-environment interaction between the brain-derived neurotrophic factor Val66Met polymorphism, psychosocial stress and dietary intake in early psychosis. Early Intervention in Psychiatry 12:5, pages 811-820.
Crossref
Crossref
Sridevi Krishnan, Karan Agrawal, Rebecca R. Tryon, Lucas C. Welch, William F. Horn, John W. Newman & Nancy L. Keim. (2018) Structural equation modeling of food craving across the menstrual cycle using behavioral, neuroendocrine, and metabolic factors. Physiology & Behavior 195, pages 28-36.
Crossref
Crossref
Jenni Kononoff, Philippe A. Melas, Marsida Kallupi, Giordano de Guglielmo, Adam Kimbrough, Maria Scherma, Paola Fadda, Denise B. Kandel, Eric R. Kandel & Olivier George. (2018) Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood. Scientific Reports 8:1.
Crossref
Crossref
F. Scheffler, S. Kilian, B. Chiliza, L. Asmal, L. Phahladira, S. du Plessis, M. Kidd, R.M. Murray, M. Di Forti, S. Seedat & R. Emsley. (2018) Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders. Schizophrenia Research 199, pages 90-95.
Crossref
Crossref
Bláthnaid McCoy, Laura Wang, Maria Zak, Sameer Al‐Mehmadi, Nadia Kabir, Kenda Alhadid, Kyla McDonald, Grace Zhang, Rohit Sharma, Robyn Whitney, Katia Sinopoli & O. Carter SneadIIIIII. (2018)
A prospective open‐label trial of a
CBD
/
THC
cannabis oil in dravet syndrome
. Annals of Clinical and Translational Neurology 5:9, pages 1077-1088.
Crossref
Crossref
Fernanda P. Moreira, Carolina D. Wiener, Jacqueline F. de Oliveira, Luciano D.M. Souza, Ricardo A. da Silva, Luis V. Portela, Diogo R. Lara, Karen Jansen & Jean Pierre Oses. (2018) Gender differences of cannabis smoking on serum leptin levels: population-based study. Revista Brasileira de Psiquiatria 40:2, pages 216-219.
Crossref
Crossref
Kristina T. Phillips, Trent L. Lalonde, Michael M. Phillips & Maryia M. Schneider. (2017) Marijuana use and associated motives in Colorado university students. The American Journal on Addictions 26:8, pages 830-837.
Crossref
Crossref
Silvia Gancheva, Bistra Galunska & Maria Zhelyazkova-Savova. (2017) Diets rich in saturated fat and fructose induce anxiety and depression-like behaviours in the rat: is there a role for lipid peroxidation?. International Journal of Experimental Pathology 98:5, pages 296-306.
Crossref
Crossref
Benjamin K. Lau, Daniela Cota, Luigia Cristino & Stephanie L. Borgland. (2017) Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology 124, pages 38-51.
Crossref
Crossref
Rui S. Rodrigues, Filipa F. Ribeiro, Filipa Ferreira, Sandra H. Vaz, Ana M. Sebastião & Sara XapelliXapelliXapelli. (2017) Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis. Frontiers in Pharmacology 8.
Crossref
Crossref
Miriam Schneider, Beth Levant, Martin Reichel, Erich Gulbins, Johannes Kornhuber & Christian P. Müller. (2017) Lipids in psychiatric disorders and preventive medicine. Neuroscience & Biobehavioral Reviews 76, pages 336-362.
Crossref
Crossref
Antonia Sophocleous, Roy Robertson, Nuno B. Ferreira, James McKenzie, William D. Fraser & Stuart H. Ralston. (2017) Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures. The American Journal of Medicine 130:2, pages 214-221.
Crossref
Crossref
Joseph J. Sabia, Jeffrey Swigert & Timothy Young. (2017) The Effect of Medical Marijuana Laws on Body Weight. Health Economics 26:1, pages 6-34.
Crossref
Crossref
Jonathan Cedernaes, Flaminia Fanelli, Alessia Fazzini, Uberto Pagotto, Jan-Erik Broman, Heike Vogel, Suzanne L. Dickson, Helgi B. Schiöth & Christian Benedict. (2016) Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans. Psychoneuroendocrinology 74, pages 258-268.
Crossref
Crossref
Jenny L. Wiley, Timothy W. Lefever, Nikita S. Pulley, Julie A. Marusich, Benjamin F. Cravatt & Aron H. Lichtman. (2016) Just add water: cannabinoid discrimination in a water T-maze with FAAH(−/−) and FAAH(+/+) mice. Behavioural Pharmacology 27:5, pages 479-484.
Crossref
Crossref
J Ceccarini, N Weltens, H G Ly, J Tack, L Van Oudenhove & K Van Laere. (2016) Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [18F]MK-9470 PET study. Translational Psychiatry 6:7, pages e853-e853.
Crossref
Crossref
Concepción García, Cristina Palomo‐Garo, Yolanda Gómez‐Gálvez & Javier Fernández‐Ruiz. (2015) Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia. British Journal of Pharmacology 173:13, pages 2069-2079.
Crossref
Crossref
Alexander Edwards & Alfonso Abizaid. (2016) Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems. Neuroscience & Biobehavioral Reviews 66, pages 33-53.
Crossref
Crossref
Antoni Pastor, Fernando Fernández-Aranda, Montserrat Fitó, Susana Jiménez-Murcia, Cristina Botella, Jose M. Fernández-Real, Gema Frühbeck, Francisco J. Tinahones, Ana B. Fagundo, Joan Rodriguez, Zaida Agüera, Klaus Langohr, Felipe F. Casanueva & Rafael de la Torre. (2016) A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women. PLOS ONE 11:2, pages e0148734.
Crossref
Crossref
A. K. Danielsson, A. Lundin, A. Yaregal, C. G. Östenson, P. Allebeck & E. E. Agardh. (2016) Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women. Journal of Diabetes Research 2016, pages 1-6.
Crossref
Crossref
Ashley E. Mason, Barbara Laraia, Jennifer Daubenmier, Frederick M. Hecht, Robert H. Lustig, Eli Puterman, Nancy Adler, Mary Dallman, Michaela Kiernan, Ashley N. Gearhardt & Elissa S. Epel. (2015) Putting the brakes on the “drive to eat”: Pilot effects of naltrexone and reward-based eating on food cravings among obese women. Eating Behaviors 19, pages 53-56.
Crossref
Crossref
Arnau Busquets-Garcia, Tifany Desprez, Mathilde Metna-Laurent, Luigi Bellocchio, Giovanni Marsicano & Edgar Soria-Gomez. (2015)
Dissecting the cannabinergic control of behavior: The
where
matters
. BioEssays 37:11, pages 1215-1225.
Crossref
Crossref
D. Matthew Walentiny, Robert E. Vann & Jenny L. Wiley. (2015) Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Neuropharmacology 93, pages 237-242.
Crossref
Crossref
Melissa Ochoa, Jean-Paul Lallès, Charles-Henri Malbert & David Val-Laillet. (2014) Dietary sugars: their detection by the gut–brain axis and their peripheral and central effects in health and diseases. European Journal of Nutrition 54:1, pages 1-24.
Crossref
Crossref
Claudia Sagheddu, Anna Lisa Muntoni, Marco Pistis & Miriam Melis. 2015. Endocannabinoids. Endocannabinoids
257
302
.
Angelo Blasio, Kenner C. Rice, Valentina Sabino & Pietro Cottone. (2014) Characterization of a shortened model of diet alternation in female rats. Behavioural Pharmacology 25:7, pages 609-617.
Crossref
Crossref
Chris M Friemel, Andreas Zimmer & Miriam Schneider. (2014) The CB1 Receptor as an Important Mediator of Hedonic Reward Processing. Neuropsychopharmacology 39:10, pages 2387-2396.
Crossref
Crossref
A. Galanopoulos, A. Polissidis, G. Georgiadou, Z. Papadopoulou-Daifoti, G.G. Nomikos, N. Pitsikas & K. Antoniou. (2014) WIN55,212-2 impairs non-associative recognition and spatial memory in rats via CB1 receptor stimulation. Pharmacology Biochemistry and Behavior 124, pages 58-66.
Crossref
Crossref
Fernando Fernández-Aranda, Sarah Sauchelli, Antoni Pastor, Marcela L. Gonzalez, Rafael de la Torre, Roser Granero, Susana Jiménez-Murcia, Rosa Baños, Cristina Botella, Jose M. Fernández-Real, Jose C. Fernández-García, Gema Frühbeck, Javier Gómez-Ambrosi, Roser Rodríguez, Francisco J. Tinahones, Jon Arcelus, Ana B. Fagundo, Zaida Agüera, Jordi Miró & Felipe F. Casanueva. (2014) Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament. PLoS ONE 9:8, pages e104534.
Crossref
Crossref
Javier Fernández‐Ruiz, Mariluz Hernández & Yolanda García‐Movellán. 2014. Cannabinoids. Cannabinoids
175
218
.
Paula J. Edge & Mark S. Gold. (2014) Potential Role of Addiction Pharmacotherapy in Problematic Eating Behavior. Current Addiction Reports 1:2, pages 83-88.
Crossref
Crossref
Jaime G Maldonado-Avilés & Ralph J DiLeone. (2014) Inhaling: endocannabinoids and food intake. Nature Neuroscience 17:3, pages 336-337.
Crossref
Crossref
Jaume F. Lalanza, Antoni Caimari, Josep M. del Bas, Daniel Torregrosa, Igor Cigarroa, Mercè Pallàs, Lluís Capdevila, Lluís Arola & Rosa M. Escorihuela. (2014) Effects Of A Post-Weaning Cafeteria Diet In Young Rats: Metabolic Syndrome, Reduced Activity And Low Anxiety-Like Behaviour. PLoS ONE 9:1, pages e85049.
Crossref
Crossref
Ian James Martins & Rhona Creegan. (2014) Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer’s Disease. Health 06:12, pages 1549-1579.
Crossref
Crossref
Angelo Blasio, Attilio Iemolo, Valentina Sabino, Stefania Petrosino, Luca Steardo, Kenner C Rice, Pierangelo Orlando, Fabio Arturo Iannotti, Vincenzo Di Marzo, Eric P Zorrilla & Pietro Cottone. (2013) Rimonabant Precipitates Anxiety in Rats Withdrawn from Palatable Food: Role of the Central Amygdala. Neuropsychopharmacology 38:12, pages 2498-2507.
Crossref
Crossref
Sarah M. Minney & Hassan H. López. (2013) Adolescent cannabinoid treatment negatively affects reproductive behavior in female rats. Pharmacology Biochemistry and Behavior 112, pages 82-88.
Crossref
Crossref
Garron T. Dodd, Amy A. Worth, Duncan J. Hodkinson, Raj K. Srivastava, Beat Lutz, Steve R. Williams & Simon M. Luckman. (2013) Central functional response to the novel peptide cannabinoid, hemopressin. Neuropharmacology 71, pages 27-36.
Crossref
Crossref
F. L. Wright & R. J. Rodgers. (2012) Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats. Psychopharmacology 226:2, pages 415-431.
Crossref
Crossref
Elżbieta Radziszewska & Ewa Bojanowska. (2013) Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2. Medical Science Monitor Basic Research 19, pages 6-11.
Crossref
Crossref
R. John Rodgers, Matthias H. Tschöp & John P. H. Wilding. (2012) Anti-obesity drugs: past, present and future. Disease Models & Mechanisms 5:5, pages 621-626.
Crossref
Crossref
Mónica Méndez‐Díaz, Pavel Ernesto Rueda‐Orozco, Alejandra Evelyn Ruiz‐Contreras & Oscar Prospéro‐García. (2010) The endocannabinoid system modulates the valence of the emotion associated to food ingestion. Addiction Biology 17:4, pages 725-735.
Crossref
Crossref
Julie A. Marusich & Jenny L. Wiley. (2012) Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure. Pharmacology Biochemistry and Behavior 101:4, pages 575-580.
Crossref
Crossref
Katrina Weston-Green, Xu-Feng Huang & Chao Deng. (2012) Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain. PLoS ONE 7:3, pages e33548.
Crossref
Crossref
Kwang-Mook Jung, Jason R. Clapper, Jin Fu, Giuseppe D'Agostino, Ana Guijarro, Dean Thongkham, Agnesa Avanesian, Giuseppe Astarita, Nicholas V. DiPatrizio, Andrea Frontini, Saverio Cinti, Sabrina Diano & Daniele Piomelli. (2012) 2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism. Cell Metabolism 15:3, pages 299-310.
Crossref
Crossref
Theresa Brand, Rainer Spanagel & Miriam Schneider. (2012) Decreased Reward Sensitivity in Rats from the Fischer344 Strain Compared to Wistar Rats Is Paralleled by Differences in Endocannabinoid Signaling. PLoS ONE 7:2, pages e31169.
Crossref
Crossref
Alin Andries & René Klinkby Støving. (2011) Cannabinoid-1 receptor agonists: a therapeutic option in severe, chronic anorexia nervosa?. Neuropsychiatry 1:5, pages 467-476.
Crossref
Crossref
T. P. MIDDLETON & D. A. PROTTI. (2011) Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells. Visual Neuroscience 28:5, pages 393-402.
Crossref
Crossref
Richard J Ward, John D Pediani & Graeme Milligan. (2011) Ligand-induced internalization of the orexin OX1 and cannabinoid CB1 receptors assessed via N-terminal SNAP and CLIP-tagging. British Journal of Pharmacology 162:6, pages 1439-1452.
Crossref
Crossref
Cristian A. Pérez, Sarah A. Stanley, Robert W. Wysocki, Jana Havranova, Rebecca Ahrens-Nicklas, Frances Onyimba & Jeffrey M. Friedman. (2011) Molecular Annotation of Integrative Feeding Neural Circuits. Cell Metabolism 13:2, pages 222-232.
Crossref
Crossref
Paul J. Fletcher & Guy A. Higgins. 2011. 5-HT2C Receptors in the Pathophysiology of CNS Disease. 5-HT2C Receptors in the Pathophysiology of CNS Disease
293
324
.
Bruce A. Watkins, Heather Hutchins, Yong Li & Mark F. Seifert. (2010) The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health. The Journal of Nutritional Biochemistry 21:12, pages 1141-1152.
Crossref
Crossref
Susana Peciña & Kyle S. Smith. (2010) Hedonic and motivational roles of opioids in food reward: Implications for overeating disorders. Pharmacology Biochemistry and Behavior 97:1, pages 34-46.
Crossref
Crossref
A.J. Tallett, J.E. Blundell & R.J. Rodgers. (2010) Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats. Pharmacology Biochemistry and Behavior 97:1, pages 92-100.
Crossref
Crossref
Edgar Soria-Gómez, Marianela I. Márquez-Diosdado, Corinne J. Montes-Rodríguez, Vicente Estrada-González & Oscar Prospéro-García. (2010) Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors. The International Journal of Neuropsychopharmacology 13:09, pages 1247-1254.
Crossref
Crossref
Celia JA Morgan, Tom P Freeman, Gráinne L Schafer & H Valerie Curran. (2010) Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis. Neuropsychopharmacology 35:9, pages 1879-1885.
Crossref
Crossref
Mauro Mauri, Alba Calderone, Anna Romano, Pasquale Fabio Calabrò, Samanta Augusto & Chita Lippi. (2014) Alterazioni ormonali nei disturbi della condotta alimentare. L'Endocrinologo 11:4, pages 159-165.
Crossref
Crossref
Javier Fernández‐Ruiz, Mariluz Hernández & José A. Ramos. (2010) Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders. CNS Neuroscience & Therapeutics 16:3.
Crossref
Crossref
Garron T. Dodd, Giacomo Mancini, Beat Lutz & Simon M. Luckman. (2010)
The Peptide Hemopressin Acts through CB
1
Cannabinoid Receptors to Reduce Food Intake in Rats and Mice
. The Journal of Neuroscience 30:21, pages 7369-7376.
Crossref
Crossref
Mathias Rask-Andersen, Pawel K. Olszewski, Allen S. Levine & Helgi B. Schiöth. (2010) Molecular mechanisms underlying anorexia nervosa: Focus on human gene association studies and systems controlling food intake. Brain Research Reviews 62:2, pages 147-164.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Lipidology 21:1, pages 84-88.
Crossref
Crossref